Kenneth I. Maynard

2.8k total citations
49 papers, 1.7k citations indexed

About

Kenneth I. Maynard is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Kenneth I. Maynard has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Kenneth I. Maynard's work include Nitric Oxide and Endothelin Effects (11 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroscience and Neuropharmacology Research (11 papers). Kenneth I. Maynard is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Neuropeptides and Animal Physiology (11 papers) and Neuroscience and Neuropharmacology Research (11 papers). Kenneth I. Maynard collaborates with scholars based in United States, United Kingdom and Taiwan. Kenneth I. Maynard's co-authors include Michael A. Moskowitz, Issam A. Ayoub, Christopher S. Ogilvy, Geoffrey Burnstock, Naoki Koketsu, Solomon H. Snyder, Ted M. Dawson, Kazuhiko Nozaki, David S. Bredt and Yohtaro Sakakibara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Stroke and Brain Research.

In The Last Decade

Kenneth I. Maynard

49 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kenneth I. Maynard 529 456 416 311 267 49 1.7k
Ferenc Domoki 520 1.0× 505 1.1× 609 1.5× 387 1.2× 209 0.8× 81 2.0k
D. Duverger 503 1.0× 695 1.5× 486 1.2× 418 1.3× 250 0.9× 24 1.6k
Enrique Alborch 568 1.1× 297 0.7× 538 1.3× 260 0.8× 308 1.2× 93 1.8k
R. Sercombe 408 0.8× 564 1.2× 484 1.2× 252 0.8× 651 2.4× 73 2.0k
Hans H. Dietrich 1.1k 2.0× 227 0.5× 559 1.3× 269 0.9× 486 1.8× 45 2.4k
B. Joy Snider 561 1.1× 511 1.1× 700 1.7× 210 0.7× 142 0.5× 44 1.8k
Nobuo Araki 335 0.6× 321 0.7× 409 1.0× 319 1.0× 186 0.7× 89 1.3k
Dirk Megow 512 1.0× 673 1.5× 915 2.2× 565 1.8× 512 1.9× 33 2.9k
Eva Westerberg 382 0.7× 889 1.9× 771 1.9× 247 0.8× 262 1.0× 39 2.0k
B. K. Siesj� 408 0.8× 1.2k 2.6× 768 1.8× 545 1.8× 458 1.7× 23 2.4k

Countries citing papers authored by Kenneth I. Maynard

Since Specialization
Citations

This map shows the geographic impact of Kenneth I. Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth I. Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth I. Maynard more than expected).

Fields of papers citing papers by Kenneth I. Maynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth I. Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth I. Maynard. The network helps show where Kenneth I. Maynard may publish in the future.

Co-authorship network of co-authors of Kenneth I. Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth I. Maynard. A scholar is included among the top collaborators of Kenneth I. Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth I. Maynard. Kenneth I. Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freedland, Eric S., et al.. (2021). Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities. Drug Safety. 44(8). 843–852. 9 indexed citations
2.
3.
4.
Crespigny, Alex J. de, Helen D’Arceuil, Kenneth I. Maynard, et al.. (2005). Acute studies of a new primate model of reversible middle cerebral artery occlusion. Journal of Stroke and Cerebrovascular Diseases. 14(2). 80–87. 54 indexed citations
5.
Maynard, Kenneth I., Stacey J. Sukoff Rizzo, Zhongqi Ji, Joseph G. Wettstein, & Mark D. Black. (2005). The acoustic startle reflex in Sprague-Dawley rats is altered by permanent middle cerebral artery occlusion. Brain Research. 1032(1-2). 44–49. 1 indexed citations
6.
Petty, Margaret A., Philip M. Weintraub, & Kenneth I. Maynard. (2004). ACEA 1021: Flip or Flop?. CNS Drug Reviews. 10(4). 337–348. 3 indexed citations
7.
Ayoub, Issam A. & Kenneth I. Maynard. (2002). Therapeutic window for nicotinamide following transient focal cerebral ischemia. Neuroreport. 13(2). 213–216. 35 indexed citations
8.
Maynard, Kenneth I., Issam A. Ayoub, & Chiung‐Chyi Shen. (2001). Delayed Multidose Treatment with Nicotinamide Extends the Degree and Duration of Neuroprotection by Reducing Infarction and Improving Behavioral Scores up to Two Weeks Following Transient Focal Cerebral Ischemia in Wistar Rats. Annals of the New York Academy of Sciences. 939(1). 416–424. 23 indexed citations
9.
Quiñones‐Hinojosa, Alfredo, Adelbert Ames, Junaid Y. Malek, & Kenneth I. Maynard. (1999). An in vitro rabbit retina model to study electrophysiologic and metabolic function during and following ischemia. Journal of Neuroscience Methods. 90(2). 107–115. 7 indexed citations
10.
Maynard, Kenneth I., Pablo Arango, David Chen, & Christopher S. Ogilvy. (1998). Acetylsalicyclate administered during simulated ischemia reduces the recovery of neuronal function in the in vitro rabbit retina. Neuroscience Letters. 249(2-3). 159–162. 14 indexed citations
11.
Maynard, Kenneth I., et al.. (1998). Avoiding stroke during cerebral arterial occlusion by temporarily blocking neuronal functions in the rabbit. Journal of Stroke and Cerebrovascular Diseases. 7(5). 287–295. 13 indexed citations
12.
Maynard, Kenneth I., David Chen, Pablo Arango, & Christopher S. Ogilvy. (1996). Nitric oxide produced during ischemia improves functional recovery in the rabbit retina. Neuroreport. 8(1). 81–85. 16 indexed citations
13.
Maynard, Kenneth I. & Christopher S. Ogilvy. (1995). Patterns of peptide-containing perivascular nerves in the circle of Willis: their absence in intracranial arteriovenous malformations. Journal of neurosurgery. 82(5). 829–833. 13 indexed citations
14.
Maynard, Kenneth I. & Geoffrey Burnstock. (1994). Evoked noradrenaline release in the rabbit ear artery: enhancement by purines, attenuation by neuropeptide Y and lack of effect of calcitonin gene‐related peptide. British Journal of Pharmacology. 112(1). 123–126. 14 indexed citations
15.
Zhang, Zheng Gang, Michael Chopp, Kenneth I. Maynard, & Michael A. Moskowitz. (1994). Cerebral Blood Flow Changes during Cortical Spreading Depression are Not Altered by Inhibition of Nitric Oxide Synthesis. Journal of Cerebral Blood Flow & Metabolism. 14(6). 939–943. 33 indexed citations
16.
Münch, Götz, et al.. (1994). Effects of acrylamide on cotransmission in perivascular sympathetic and sensory nerves. Journal of the Autonomic Nervous System. 49(3). 197–205. 11 indexed citations
17.
Maynard, Kenneth I., Anne L. Stewart‐Lee, P. Milner, & Geoffrey Burnstock. (1992). X‐irradiation attenuates relaxant responses in the rabbit ear artery. British Journal of Pharmacology. 105(1). 126–128. 21 indexed citations
18.
Maynard, Kenneth I., Valerie L. Saville, & Geoffrey Burnstock. (1991). Somatostatin modulates vascular sympathetic neurotransmission in the rabbit ear artery. European Journal of Pharmacology. 196(2). 125–131. 18 indexed citations
19.
Maynard, Kenneth I., Valerie L. Saville, & Geoffrey Burnstock. (1990). Sensory-motor neuromodulation of sympathetic vasoconstriction in the rabbit central ear artery. European Journal of Pharmacology. 187(2). 171–182. 28 indexed citations
20.
Saville, Valerie L., Kenneth I. Maynard, & Geoffrey Burnstock. (1990). Neuropeptide Y potentiates purinergic as well as adrenergic responses of the rabbit ear artery. European Journal of Pharmacology. 176(2). 117–125. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferenc Domoki Breakdown of academic impact, for papers by D. Duverger Breakdown of academic impact, for papers by Enrique Alborch Breakdown of academic impact, for papers by R. Sercombe Breakdown of academic impact, for papers by Hans H. Dietrich Breakdown of academic impact, for papers by B. Joy Snider Breakdown of academic impact, for papers by Nobuo Araki Breakdown of academic impact, for papers by Dirk Megow Breakdown of academic impact, for papers by Eva Westerberg Breakdown of academic impact, for papers by B. K. Siesj�
Rankless by CCL
2026